Cholesterol dependent and Amphotericin B resistant isolates of a Candida glabrata strain from an Intensive Care Unit patient

Medical Mycology

Volumn 46, Issue 3, 2008, Pages 265-268

  Rezusta, Antonio ^a   Aspiroz, Carmen ^b   Boekhout, Tenuis ^c   Cano, Jose Francisco ^d   Theelen, Bart ^c   Guarro, Josep ^d   Rubio, Maria Carmen ^e  

^a Fac Cie de la Salud y del Deporte   (Spain)

^b HOSPITAL ROYO VILLANOVA   (Spain)

^c CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^d FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^e HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Amphotericin B; Candida glabrata; Cholesterol

Indexed keywords

AMIKACIN; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CEFTAZIDIME; CHOLESTEROL; FLUCONAZOLE; IMIPENEM; RIBOSOME DNA; TEICOPLANIN; TOBRAMYCIN; FUNGAL DNA; RIBOSOMAL SPACER DNA;

ACUTE HEMORRHAGIC PANCREATITIS; ADULT; ANTIFUNGAL RESISTANCE; ARTICLE; BILIARY PERITONITIS; CANDIDA GLABRATA; CASE REPORT; CHOLECYSTECTOMY; CHOLELITHIASIS; DNA SEQUENCE; FEMALE; FUNGEMIA; FUNGUS ISOLATION; GALLBLADDER PERFORATION; HUMAN; INTENSIVE CARE UNIT; NONHUMAN; NUCLEOTIDE SEQUENCE; SURGICAL DRAINAGE; URINALYSIS; CANDIDA; CANDIDIASIS; CLASSIFICATION; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; URINE;

CANDIDA GLABRATA;

AMPHOTERICIN B; CANDIDA; CANDIDA GLABRATA; CANDIDIASIS; CHOLESTEROL; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; INTENSIVE CARE UNITS; MIDDLE AGED; URINE;

EID: 47249130356     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780701636898     Document Type: Article

References (15)

1. Leeming, JP and Notman, FH. (1987) Improved methods for isolation and enumeration of Malassezia furfur from human skin. J Clin Microbiol, 25, pp. 2017-2019.
2. Gueho, E., Midgley, G. and Guillot, J. (1996) The genus Malassezia with description of four new species. Antonie van Leeuwenhoek, 69, pp. 337-355.
3. Gupta, AK, Boekhout, T., Theelen, B., Summerbell, R. and Batra, R. (2004) Identification and typing of Malassezia species by Amplified Fragment Length Polymorphism (AFLP) and sequence analysis of the internal transcribed spacer (ITS) and large subunit (LSU) regions of ribosomal DNA. J Clin Microbiol, 42, pp. 4253-4260.
4. Altschul, SF, Madden, TL and Schaffer, AA (1997) Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucl Acids Res, 25, pp. 3389-3402.
5. Alcoba-Florez, J., Mendez-Alvarez, S. and Cano, J. (2005) Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus. J Clin Microbiol, 43, pp. 4107-4111.
6. Correia, A., Sampaio, P., James, S. and Pais, C. (2006) Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata. Int J Syst Evol Microbiol, 56, pp. 313-317.
7. Alvarez-Lerma, F., Nolla-Salas, J. and Leon, C. (2003) EPCAN Study Group. Candiduria in critically ill patients admitted to intensive care medical units. Intens Care Med, 29, pp. 1069-1076.
8. Morera, Y., Torres-Rodriguez, JM, Catalan, I., Granadero, A., Josic, Z., Alvarez-Lerma, F. and Grup de Recerca en Micologia Experimental i Clinica (GREMEC) (2002) Candiduria in patients with urethral catheter admitted in Intensive Care Unit. Etiology and in vitro susceptibility to fluconazole. Med Clin (Barc), 118, pp. 580-582.
9. Harris, AD, Castro, J., Sheppard, DC, Carmeli, Y. and Samore, MH. (1999) Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans. Clin Infect Dis, 29, pp. 926-928.
10. Aloia, T., Solomkin, J. and Fink, AS (1994) Candida in pancreatic infection: A clinical experience. Am Surg, 60, pp. 793-796.
11. Robbins, EG, Stollman, NH, Bierman, P., Grauer, L. and Barkin, JS. (1996) Pancreatic fungal infections: A case report and review of the literature. Pancreas, 12, pp. 308-312.
12. Pfaller, MA, Messer, SA and Boyken, L. (2004) Variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: A global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002. J Clin Microbiol, 42, pp. 3142-3146.
13. Spellberg, BJ, Filler, SG and Edwards, JE. (2006) Current treatment strategies for disseminated candidiasis. Clin Infect Dis, 42, pp. 244-251.
14. Hazen, KC, Stei, J. and Darracott, C. (2005) Isolation of cholesterol-dependent Candida glabrata from clinical specimens. Diagn Microbiol Infect Dis., 52, pp. 35-37.
15. Bard, M., Sturm, AM and Pierson, CA (2005) Sterol uptake in Candida glabrata: Rescue of sterol auxotrophic strains. Diagn Microbiol Infect Dis, 52, pp. 285-293.